首页> 外国专利> AZOLic acid derivatives, whether or not combined, for the treatment of diabetes and dyslipidaemia; and for the treatment of small claims

AZOLic acid derivatives, whether or not combined, for the treatment of diabetes and dyslipidaemia; and for the treatment of small claims

机译:AZOLic衍生物,无论是否组合,用于治疗糖尿病和血脂异常;并用于处理小额索赔

摘要

Compounds are provided which have the structure wherein Q is C or N, XSUB1 /SUBis C or N, and RSUP1/SUP, RSUP2/SUP, RSUP2a/SUP, RSUP2b/SUP, RSUP2c/SUP, RSUP3/SUP, Y, A, m, n, XSUB2/SUB, XSUB3 /SUBand XSUB4 /SUBare as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents.
机译:提供具有以下结构的化合物,其中Q为C或N,X 1 为C或N,以及R 1 ,R 2 ,R 2a ,R 2b ,R 2c ,R 3 ,Y,A,m,n,X 2 ,X 3 和X 4 如本文所定义,这些化合物可用作抗糖尿病药,降血脂药和抗肥胖药。

著录项

  • 公开/公告号DE60238255D1

    专利类型

  • 公开/公告日2010-12-23

    原文格式PDF

  • 申请/专利权人 BRISTOL-MYERS SQUIBB CO.;

    申请/专利号DE20026038255T

  • 发明设计人 CHENG PETER T.;JEON YOON;WANG WEI;

    申请日2002-05-23

  • 分类号A61K31/42;A61K31/422;A61K31/454;A61K31/55;A61K45;A61P1;A61P1/04;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P19/10;A61P35;A61P43;C07D413/06;C07D413/10;C07D413/12;

  • 国家 DE

  • 入库时间 2022-08-21 17:46:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号